Holen Sie sich die Stockscreener-App
0.5673
2.76%
-0.0161
Handel nachbörslich:
.57
0.0027
+0.48%
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
HC Wainwright Boosts Earnings Estimates for Aethlon Medical - Defense World
Aethlon Medical (NASDAQ:AEMD) Receives “Buy” Rating from HC Wainwright - Defense World
Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 21.3% in January - Defense World
Aethlon Medical strengthens oncology trial with protocol updates and cost reductions - MSN
Aethlon Medical IncThe company expects to conduct a capital raise that - Smartkarma
Aethlon’s Earnings Call: Trials and Cost Strategies - TipRanks
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call Transcript - Insider Monkey
Live Investor Update: Aethlon Medical Unveils Latest Cancer Treatment ProgressCEO Takes Questions - StockTitan
Aethlon Medical operating expenses drop 50% in Q3 2024 - Medical Buyer
Earnings call transcript: Aethlon Medical Q4 2024 sees cost cuts, stock rises - Investing.com Nigeria
Aethlon Medical Reports Q3 Results and Corporate Update - TipRanks
Aethlon Medical Inc. (AEMD) reports earnings - Quartz
Aethlon Medical Achieves Milestone in Oncology Trials - TipRanks
Aethlon's Hemopurifier Cancer Trial Milestone Achieved as Q3 Expenses Drop 50% - StockTitan
Head-To-Head Review: NeuroPace (NASDAQ:NPCE) vs. Aethlon Medical (NASDAQ:AEMD) - Defense World
Critical Analysis: Aethlon Medical (NASDAQ:AEMD) and Becton, Dickinson and Company (NYSE:BDX) - Defense World
Stock Of Aethlon Medical Inc (NASDAQ: AEMD) Dropped By -13.43 Percent Over The Past Month, Is There Room For Downside? – Marketing Sentinel - Marketing Sentinel
Aethlon Medical Inc (AEMD) Stock: A Value Analysis - The News Heater
Aethlon Medical Inc (AEMD) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Aethlon Medical Q3 Earnings Preview: Cancer & Infectious Disease Pipeline Takes Center Stage - StockTitan
Exosome Diagnostics & Therapeutics Market to Grow by USD 1.01 Billion (2025-2029) with Rising Research in Exosome Therapeutics Boosting the Market, Report on How AI is Driving Market TransformationTechnavio - The Malaysian Reserve
Aethlon Medical (NASDAQ:AEMD) Earns Buy Rating from HC Wainwright - Defense World
Aethlon Medical treats first subject with Hemopurifier device in Australia - Medical Device Network
Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on Cancer Clinical Trial update - Investorideas.com newswire
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Treats First Patient in Australian Hemopurifier® Cancer Trial - Investorideas.com newswire
Aethlon announces treatment of first patient with Hemopurifier in Australia - TipRanks
Revolutionary Blood Filter Could Boost Cancer Immunotherapy Success Rates by 60% - StockTitan
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in January - Defense World
Mawson Infrastructure Group Inc. Provides Company Presentation UpdateOn January 27, 2025, Mawson Infrastructure Group Inc. (NASDAQ: MIGI) announced an updated Company Presentation, disclosing information that has been made available to the publ - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in December - Defense World
Biostage (OTCMKTS:BSTG) and Aethlon Medical (NASDAQ:AEMD) Head to Head Review - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Head-To-Head Survey: Aethlon Medical (NASDAQ:AEMD) & West Pharmaceutical Services (NYSE:WST) - Defense World
Aethlon Medical receives extension to meet Nasdaq listing requirements - Investing.com
Aethlon Medical receives extension to meet Nasdaq listing requirements By Investing.com - Investing.com UK
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update - The Eastern Progress Online
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Large Growth in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu - PR Newswire
Aethlon Medical's Hemopurifier Shows 99% Bird Flu Virus Removal in Lab Tests Amid U.S. Outbreak - StockTitan
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Head-To-Head Analysis: AtriCure (NASDAQ:ATRC) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
1.10%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):